Navigation Links
Chantix And NuvaRing Lawsuit Funding Added To Pharmaceutical Drug List At Legal-Bay
Date:6/13/2013

SAN FRANCISCO, June 13, 2013 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that they are one of the first funding firms to offer plaintiffs of both Chantix and NuvaRing litigation's with lawsuit pre-settlement funding.  Legal-Bay is a leader in both product liability funding in case of recalled hip products and transvaginal mesh cases, as well as bad pharmaceutical drugs.  The addition to begin funding Chantix and NuvaRing indicates the company's intentions to be at the forefront of funding in mass tort cases. 

(Logo: http://photos.prnewswire.com/prnh/20130613/PH30672LOGO)

"We believe both the Chantix and NuvaRing litigation represent mass tort plaintiffs with serious side effects to the drugs and product taken.  Although most companies in the legal funding community believe these litigations still pose significant risk, we remain steadfast in our commitment to assist victims of Chantix and NuvaRing who need cash to pay for bills and live until their settlement is obtained", Said Chris Janish, CEO of Legal-Bay.  Legal-Bay's NuvaRing and Chantix funding products are not lawsuit loans, as there are no monthly payments and the funds only need to be paid back if you win your case.    

Chantix the smoking cessation drug has left many people with serious bouts of depression and ultimately suicidal actions in some cases.  NuvaRing was billed as an innovative birth control option for women, however the side effects to the product included heart attack, stroke, pulmonary embolisms and vein issues. 

Chantix and NuvaRing is in addition to the following bad pharmaceutical drugs that Legal-Bay is actively funding:

  • Accutane
  • Actos
  • Avandia
  • Gadolinum
  • Prempro/HRT
  • Vioxx
  • Yaz, Yasmin, and Ocella

Legal-Bay's "Big Pharma" funding list is constantly changing, so feel free to inquire about funding on a product that you do not see above. 

If you were injured by a Chantix, NuvaRing or another pharmaceutical drug and need a lawsuit cash advance, feel free to apply online at: http://lawsuitssettlementfunding.com or by calling Legal-Bay toll free at 877.571.0405 where live agents are always available to answer your Chantix or NuvaRing Lawsuit Funding questions.  (You must have a lawyer to apply for Chantix lawsuit funding, however if you need a Chantix lawyer or NuvaRing lawyer, feel free to contact Legal-Bay and they can provide you with an attorney who will give you a free legal consultation.)

Contact:  Patty Kirby, Head of Client Relations
              Ph. 877.571.0405   Email:  Info@legal-bay.com


'/>"/>
SOURCE Legal-Bay LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RD Legal Offers Funding to Plaintiffs Attorneys with Chantix Settlements
2. Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
3. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in AMAG Pharmaceuticals, Inc. of Class Action Lawsuit Investigation - AMAG
4. Stryker And DePuy Pinnacle Hip Lawsuit Settlement News Update
5. The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders
6. Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
7. Medstrat Posts Documents Confirming Terms Of Dismissal Of Merges Lawsuit
8. Vaginal Mesh Lawsuit Website Launched by Dr. Greg Vigna
9. Medifast, Inc. Announces Favorable Resolution of Securities Class Action Lawsuit
10. Star Scientific Responds to Plaintiffs Purported Class Action Lawsuit
11. OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... India , April 29, 2016 ... Pipeline Review, H1 2016" market research report that ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:4/29/2016)... , April 29, 2016 /PRNewswire/ ... Contamine, Directeur Financier Sanofi, ... santé, publie ses résultats pour le ... du Groupe, Jérôme Contamine, commente les ... et les perspectives pour le reste ...
(Date:4/29/2016)... India , April 29, 2016 ... the life science laboratory due to the growing demands ... by advance technology, contemporary automated systems are already adept ... performed by slow, tedious and manual labor. Instrumentation continues ... were not even conceivable just a few years ago. ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... Mediware Information ... therapy software application that helps blood and marrow transplant (BMT) programs meet compliance ... launch, Mediware has continued to enhance core application features. These enhancements are designed ...
(Date:5/4/2016)... ... May 04, 2016 , ... International Conference on Obesity and ... 2016 at Las Vegas. It aims to bring together academicians, scientists, dietitians, surgeons, ... organizations across the globe; making the conference a perfect platform to share experience ...
(Date:5/3/2016)... (PRWEB) , ... May 04, 2016 , ... The ... 2016-2017 inductee into its VIP Woman of the Year Circle. She is recognized with ... exclusively for professional women, boasting more than 850,000 members and over 200 operating Local ...
(Date:5/3/2016)... , ... May 03, 2016 , ... Sue Desmond-Hellmann, chief ... of 2016 to stretch the limits of human possibility in her keynote address at ... in the Georgia Dome. , Drawing on her rich experience as a scientist, physician ...
(Date:5/3/2016)... ... May 03, 2016 , ... With the opioid epidemic now ... excessive levels of alcohol use. Alcohol and its misuse causes long-term consequences for ... the susceptibility to strokes in those 65 years and older. In addition, there ...
Breaking Medicine News(10 mins):